Literature DB >> 19759126

Cleavage specificity of the UL48 deubiquitinating protease activity of human cytomegalovirus and the growth of an active-site mutant virus in cultured cells.

Eui Tae Kim1, Se Eun Oh, Yun-Ok Lee, Wade Gibson, Jin-Hyun Ahn.   

Abstract

The human cytomegalovirus (HCMV) open reading frame UL48 encodes a 253-kDa tegument protein that is closely associated with the capsid and was recently shown to have ubiquitin-specific protease activity (J. Wang, A. N. Loveland, L. M. Kattenhorn, H. L. Ploegh, and W. Gibson, J. Virol. 80:6003-6012, 2006). Here, we examined the cleavage specificity of this deubiquitinase (DUB) and replication characteristics of an active-site mutant virus. The purified catalytic domain of the UL48 DUB (1 to 359 amino acids), corresponding to the herpes simplex virus UL36(USP) DUB (L. M. Kattenhorn, G. A. Korbel, B. M. Kessler, E. Spooner, and H. L. Ploegh, Mol. Cell 19:547-557, 2005), efficiently released ubiquitin but not ubiquitin-like modifications from a hemagglutinin peptide substrate. Mutating the active-site residues Cys24 or His162 (C24S and H162A, respectively) abolished this activity. The HCMV UL48 and HSV UL36(USP) DUBs cleaved both Lys48- and Lys63-linked ubiquitin dimers and oligomers, showing more activity toward Lys63 linkages. The DUB activity of the full-length UL48 protein immunoprecipitated from virus-infected cells also showed a better cleavage of Lys63-linked ubiquitinated substrates. An HCMV (Towne) mutant virus in which the UL48 DUB activity was destroyed [UL48(C24S)] produced 10-fold less progeny virus and reduced amounts of viral proteins compared to wild-type virus at a low multiplicity of infection. The mutant virus also produced perceptibly less overall deubiquitination than the wild-type virus. Our findings demonstrate that the HCMV UL48 DUB contains both a ubiquitin-specific carboxy-terminal hydrolase activity and an isopeptidase activity that favors ubiquitin Lys63 linkages and that these activities can influence virus replication in cultured cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759126      PMCID: PMC2786740          DOI: 10.1128/JVI.00411-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  A null mutation in the UL36 gene of herpes simplex virus type 1 results in accumulation of unenveloped DNA-filled capsids in the cytoplasm of infected cells.

Authors:  P J Desai
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 2.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

Authors:  Michael H Glickman; Aaron Ciechanover
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

3.  The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Functional map of human cytomegalovirus AD169 defined by global mutational analysis.

Authors:  Dong Yu; Maria C Silva; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

5.  Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina.

Authors:  Walter Muranyi; Jürgen Haas; Markus Wagner; Georg Krohne; Ulrich H Koszinowski
Journal:  Science       Date:  2002-08-02       Impact factor: 47.728

Review 6.  Deubiquitinating enzymes as cellular regulators.

Authors:  Jung Hwa Kim; Kyung Chan Park; Sung Soo Chung; Oksun Bang; Chin Ha Chung
Journal:  J Biochem       Date:  2003-07       Impact factor: 3.387

7.  Open reading frame UL26 of human cytomegalovirus encodes a novel tegument protein that contains a strong transcriptional activation domain.

Authors:  Thomas Stamminger; Matthias Gstaiger; Konstanze Weinzierl; Kerstin Lorz; Michael Winkler; Walter Schaffner
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells.

Authors:  Edward P Browne; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

9.  Human cytomegalovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids.

Authors:  Maria C Silva; Qian-Chun Yu; Lynn Enquist; Thomas Shenk
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Structural basis and specificity of human otubain 1-mediated deubiquitination.

Authors:  Mariola J Edelmann; Alexander Iphöfer; Masato Akutsu; Mikael Altun; Katalin di Gleria; Holger B Kramer; Edda Fiebiger; Sirano Dhe-Paganon; Benedikt M Kessler
Journal:  Biochem J       Date:  2009-03-01       Impact factor: 3.857

View more
  43 in total

1.  Random transposon-mediated mutagenesis of the essential large tegument protein pUL36 of pseudorabies virus.

Authors:  Britta S Möhl; Sindy Böttcher; Harald Granzow; Walter Fuchs; Barbara G Klupp; Thomas C Mettenleiter
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Epstein-Barr virus BPLF1 deubiquitinates PCNA and attenuates polymerase η recruitment to DNA damage sites.

Authors:  Christopher B Whitehurst; Cyrus Vaziri; Julia Shackelford; Joseph S Pagano
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64.

Authors:  Kyung-Soo Inn; Sun-Hwa Lee; Jessica Y Rathbun; Lai-Yee Wong; Zsolt Toth; Keigo Machida; Jing-Hsiung James Ou; Jae U Jung
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

4.  K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.

Authors:  Sabrina Imam; Sevnur Kömürlü; Jessica Mattick; Anastasia Selyutina; Sarah Talley; Amani Eddins; Felipe Diaz-Griffero; Edward M Campbell
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

5.  Autocatalytic activity of the ubiquitin-specific protease domain of herpes simplex virus 1 VP1-2.

Authors:  M Bolstad; F Abaitua; C M Crump; P O'Hare
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

6.  Role of PDGF receptor-α during human cytomegalovirus entry into fibroblasts.

Authors:  Kai Wu; Adam Oberstein; Wei Wang; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

7.  Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.

Authors:  Shinichi Saito; Takayuki Murata; Teru Kanda; Hiroki Isomura; Yohei Narita; Atsuko Sugimoto; Daisuke Kawashima; Tatsuya Tsurumi
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

8.  The Rad6/18 ubiquitin complex interacts with the Epstein-Barr virus deubiquitinating enzyme, BPLF1, and contributes to virus infectivity.

Authors:  Ravindra Kumar; Christopher B Whitehurst; Joseph S Pagano
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

9.  The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.

Authors:  Ossie F Dyson; Joseph S Pagano; Christopher B Whitehurst
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

Review 10.  Deubiquitinating enzymes as promising drug targets for infectious diseases.

Authors:  Bindu Nanduri; Akamol E Suvarnapunya; Malabi Venkatesan; Mariola J Edelmann
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.